Functional analysis of DNA methylation in lung cancer

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 9, 2013, Pages 1191-1197

  Li, B ^a,b   Lu, Q ^c   Song, Z G ^a   Yang, L ^a   Jin, H ^a   Li, Z G ^a   Zhao, T J ^a   Bai, Y F ^a   Zhu, J ^a   Chen, H Z ^a   Xu, Z Y ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b 411nd Hospital of PLA   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; Gene Ontology; Lung cancer; MicroRNA; Pathway; Transcription factor

Indexed keywords

MICRORNA; TRANSCRIPTION FACTOR;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BINDING SITE; CALCIUM SIGNALING; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DNA METHYLATION; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MAPPING; GENOME; GENOME IMPRINTING; HEART CONTRACTION; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNE RESPONSE; ION TRANSPORT; LUNG CANCER; NUCLEOTIDE SEQUENCE; TRANSCRIPTION REGULATION;

DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; LUNG NEOPLASMS; MICRORNAS; TRANSCRIPTION FACTORS;

EID: 84878610056     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. STERNER-KOCK A, THOREY IS, KOLI K, WEMPE F, OTTE J, BANGSOW T, KUHLMEIER K, KIRCHNER T, JIN S, KESKI-OJA J, VON MELCHNER H. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev 2002; 16: 2264-2273.
2. COLLINS LG, HAINES C, PERKEL R, ENCK RE. Lung cancer: diagnosis and management. Am Family Phys 2007; 75: 56-63.
3. FERLAY J, SHIN HR, BRAY F, FORMAN D, MATHERS C, PARKIN DM. Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer 2010; 127: 2893-2917.
4. LOKK K, VOODER T, KOLDE R, VÄLK K, VÕSA U, ROOSIPUU R, MILANI L, FISCHER K, KOLTSINA M, URGARD E. Methylation markers of early-stage nonsmall cell lung cancer. PLoS One 2012; 7: e39813.
5. PARK JY, KIM D, YANG M, PARK HY, LEE SH, RINCON M, KREAHLING J, PLASS C, SMIRAGLIA DJ, TOCKMAN MS, KIM SJ. Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer. Lung Cancer 2012; 79: 198-204.
6. TEKPLI X, LANDVIK NE, ANMARKUD KH, SKAUG V, HAUGEN A, ZIENOLDDINY S. DNA methylation at promoter regions of interleukin 1b, interleukin 6, and interleukin 8 in non-small cell lung cancer. Cancer Immunol Immunother 2013; 62: 337-345.
7. CARVALHO RH, HABERLE V, HOU J, VAN GENT T, THONGJUEA S, VAN IJCKEN W, KOCKX C, BROUWER R, RIJKERS E, SIEUWERTS A. Genome-wide DNA methylation profiling of non-small cell lung carcinomas. Epigenetics Chromatin 2012; 5: 9.
8. BRENA RM, MORRISON C, LIYANARACHCHI S, JARJOURA D, DAVULURI RV, OTTERSON GA, REISMAN D, GLAROS S, RUSH LJ, PLASS C. Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer. PLoS Med 2007; 4: e108.
9. APORNTEWAN C, PHOKAEW C, PIRIYAPONGSA J, NGAMPHIW C, ITTIWUT C, TONGSIMA S, MUTIRANGURA A. Hypomethylation of intragenic LINE-1 represses transcription in cancer cells through AGO2. PLoS One 2011; 6: e17934.
10. TANG H, GOLDBERG E. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation. J Androl 2009; 30: 157-167.
11. BRUECKNER B, STRESEMANN C, KUNER R, MUND C, MUSCH T, MEISTER M, SÜLTMANN H, LYKO F. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 2007; 67: 1419-1423.
12. URGARD E, VOODER T, VOSA U, VALK K, LIU M, LUO C, HOTI F, ROOSIPUU R, ANNILO T, LAINE J, FRENZ CM, ZHANG L, METSPALU A. Metagenes associated with survival in non-small cell lung cancer. Cancer Inform 2011; 10: 175-183.
13. WEI S, WANG LE, MCHUGH MK, HAN Y, XIONG M, AMOS CI, SPITZ MR, WEI QW. Genome-wide geneenvironment interaction analysis for asbestos exposure in lung cancer susceptibility. Carcinogenesis 2012; 33: 1531-1537.
14. OCAK S, YAMASHITA H, UDYAVAR AR, MILLER AN, GONZALEZ AL, ZOU Y, JIANG A, YI Y, SHYR Y, ESTRADA L, QUARANTA V, MASSION PP. DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway. Oncogene 2010; 29: 6331-6342.
15. DONNEM T, FENTON CG, LONVIK K, BERG T, EKLO K, ANDERSEN S, STENVOLD H, AL-SHIBLI K, AL-SAAD S, BREMNES RM, BUSUND LT. Microrna signatures in tumor tissue related to angiogenesis in non-small cell lung cancer. PloS One 2012; 7: e29671.
16. SELAMAT SA, CHUNG BS, GIRARD L, ZHANG W, ZHANG Y, CAMPAN M, SIEGMUND KD, KOSS MN, HAGEN JA, LAM WL, LAM S, GAZDAR AF, LAIRD-OFFRINGA IA. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mrna expression. Genome Res 2012; 22: 1197-1211.
17. SHARMA S, STOLINA M, LUO J, STRIETER RM, BURDICK M, ZHU LX, BATRA RK, DUBINETT SM. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo. J Immunol 2000; 164: 4558-4563.
18. HUANG DA W, SHERMAN BT, LEMPICKI RA. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37: 1-13.
19. YIN LJ, ZHANG Y, LV PP, HE WH, WU YT, LIU AX, DING GL, DONG MY, QU F, XU CM, ZHU XM, HUANG HF. Insufficient maintenance DNA methylation is associated with abnormal embryonic development. BMC Med 2012; 10: 26.
20. LI E, BEARD C, JAENISCH R. Role for DNA methylation in genomic imprinting. Nature 1993; 366: 362-365.
21. MATYS V, KEL-MARGOULIS OV, FRICKE E, LIEBICH I, LAND S, BARRE-DIRRIE A, REUTER I, CHEKMENEV D, KRULL M, HORNISCHER K, VOSS N, STEGMAIER P, LEWICKI-POTAPOV B, SAXEL H, KEL AE, WINGENDER E. Transfac and its module transcompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 2006; 34: D108-110.
22. WANG J, LU M, QIU C, CUI Q. Transmir: a transcription factor-microrna regulation database. Nucleic Acids Res 2010; 38: D119-122.
23. NOUSHMEHR H, WEISENBERGER DJ, DIEFES K, PHILLIPS HS, PUJARA K, BERMAN BP, PAN F, PELLOSKI CE, SULMAN EP, BHAT KP, VERHAAK RG, HOADLEY KA, HAYES DN, PEROU CM, SCHMIDT HK, DING L, WILSON RK, VAN DEN BERG D, SHEN H, BENGTSSON H, NEUVIAL P, COPE LM, BUCKLEY J, HERMAN JG, BAYLIN SB, LAIRD PW, ALDAPE K. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010; 17: 510-522.
24. O'BRIEN P, MORIN P, OUELLETTE RJ, ROBICHAUD GA. The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease. Cancer Res 2011; 71: 7345-7350.
25. DESAI S, MAURIN M, SMITH MA, BOLICK SC, DESSUREAULT S, TAO J, SOTOMAYOR E, WRIGHT KL. PRDM1 is required for mantle cell lymphoma response to bortezomib. Mol Cancer Res 2010; 8: 907-918.
26. PESEK M, KOPECKOVA M, BENESOVA L, MESZAROSOVA A, MUKENSNABL P, BRUHA F, MINARIK M. Clinical significance of hypermethylation status in NSCLC: Evaluation of a 30-gene panel in patients with advanced disease. Anticancer Res 2011; 31: 4647-4652.
27. LI X, CHEUNG K, MA X, TIAN L, ZHAO J, GO M, SHEN B, CHENG A, YING J, TAO Q. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients. Oncogene 2011; 31: 3419-3430.
28. TULLO A, MASTROPASQUA G, BOURDON JC, CENTONZE P, GOSTISSA M, COSTANZO A, LEVRERO M, DEL SAL G, SACCONE C, SBISA E. Adenosine deaminase, a key enzyme in DNA precursors control, is a new p73 target. Oncogene 2003; 22: 8738-8748.
29. LEFKIMMIATIS K, CARATOZZOLO MF, MERLO P, D'ERCHIA AM, NAVARRO B, LEVRERO M, TULLO A. P73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes. Cancer Res 2009; 69: 8563-8571.
30. OCANA I, MARTINEZ-VAZQUEZ J, SEGURA R, FERNANDEZDE- SEVILLA T, CAPDEVILA J. Adenosine deaminase in pleural fluids. Test for diagnosis of tuberculous pleural effusion. Chest 1983; 84: 51.
31. SAMARA I, BAKAKOS P, ORPHANIDOU D, LATSI P, KATSIMPOULA S, PAPAETIS GS, DIMAKOU K. Sputum adenosine deaminase activity in patients with pulmonary tuberculosis and lung cancer. Adv Clin Exp Med 2007; 16: 533.
32. BÖHM M, LOCKE W, SUTHERLAND R, KENCH J, HENSHALL S. A role for GATA2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes. Oncogene 2009; 28: 3847-3856.
33. SCHANG AL, GRANGER A, QUÉRAT B, BLEUX C, COHENTANNOUDJI J, LAVERRIÈRE J-N. GATA2-induced silencing and lim-homeodomain protein-induced activation are mediated by a bi-functional response element in the rat gnrh receptor gene. Mol Endocrinol 2013; 27: 74-91.
34. KUMAR MS, DOWNWARD J. Abstract a26: GATA2 is necessary for oncogene-mutant non-small cell lung tumorigenesis. Clin Cancer Res 2012; 18: A26-A26.
35. KUMAR MS, HANCOCK DC, MOLINA-ARCAS M, STECKEL M, EAST P, DIEFENBACHER M, ARMENTEROS-MONTERROSO E, LASSAILLY F, MATTHEWS N, NYE E. The GATA2 transcriptional network is requisite for RAS oncogene- driven non-small cell lung cancer. Cell 2012; 149: 642-655.
36. BAI J, HU S. Transcriptome network analysis reveals potential candidate genes for squamous lung cancer. Int J Mol Med 2012; 29: 95-101.
37. BAN J, JUG G, MESTDAGH P, SCHWENTNER R, KAUER M, ARYEE D, SCHAEFER K, NAKATANI F, SCOTLANDI K, REITER M. Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma.Oncogene 2011; 30: 2173-2180.
38. DE VITO C, RIGGI N, SUVA ML, JANISZEWSKA M, HORLBECK J, BAUMER K, PROVERO P, STAMENKOVIC I. Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development. PLoS One 2011; 6: e23592.
39. BERGER SL. Histone modifications in transcriptional regulation. Curr Opin Genet Dev 2002; 12: 142-148.